Romanian Drug Quality Defended

13 January 1997

The quality of Romanian drugs is no different from that of imports,insofar as their active ingredients are the same, Misu Moscovici, general manager of the Chemical-Pharmaceutical Research Institute, has told the Romanian Business Journal, although the special formulation of foreign-made products gives them a higher bioavailability.

The official also said that at a recent exhibition organized by the Institute, which was supposed to be devoted to novel medicines, a number of foreign producers exhibited old drugs which had been made in Romania "years ago," including antibiotics and cardiovascular treatments.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight